A comprehensive 47-target multiplex real-time RT-PCR panel for rapid qualitative detection of respiratory viruses, bacterial pneumonia pathogens, atypical organisms, and antimicrobial resistance genes. Covers SARS-CoV-2, Influenza A/B/C, RSV, Mycobacterium tuberculosis, and more — from a single upper or lower respiratory specimen.
Respiratory infections are the most common cause of hospitalization worldwide, with overlapping clinical presentations making it difficult to distinguish viral, bacterial, and atypical causes on clinical grounds alone. Rapid, comprehensive pathogen identification is essential for appropriate antimicrobial prescribing.
The Genplex™ Respiratory & Pneumonia Panel covers 17 viral targets including SARS-CoV-2, Influenza A/B/C, H1N1, H3N2, RSV, Adenovirus, Coronavirus subtypes, and more — plus 15 bacterial targets, 5 atypical organisms (including Mycoplasma, Legionella, Chlamydia pneumoniae, Bordetella pertussis, MTB/NTM), and 7 AMR resistance genes.
All targets are detected from a single upper or lower respiratory specimen, delivering a comprehensive infection profile for community-acquired pneumonia, healthcare-associated pneumonia, and emerging respiratory disease outbreaks.
Advanced molecular diagnostic capabilities engineered for clinical excellence and research-grade precision.
The broadest respiratory panel — covering viral, bacterial, atypical, and AMR targets in a single multiplexed assay.
Faster than conventional culture and serology — enabling prompt clinical management of respiratory illness.
Molecular precision ensures reliable detection of respiratory pathogens even at low viral or bacterial loads.
7 AMR markers co-detected alongside pathogens — supporting antimicrobial stewardship from a single run.
Includes SARS-CoV-2 alongside seasonal Influenza A/B/C, H1N1, H3N2, RSV, and Coronavirus subtypes.
Detects Mycoplasma pneumoniae, Legionella pneumophila, Chlamydia pneumoniae, Bordetella pertussis, and MTB.
Comprehensive multiplex detection covering a broad spectrum of clinically relevant pathogens and resistance markers.
Designed for diverse diagnostic and research use cases across the clinical spectrum.
Rapid identification of bacterial and viral causes of community-acquired pneumonia for targeted therapy.
Broad pathogen and AMR profiling in hospitalized patients with nosocomial respiratory infections.
Differentiate SARS-CoV-2 from seasonal influenza and other respiratory viruses in a single test.
Direct detection of Mycobacterium tuberculosis (MTB) and NTM from respiratory specimens.
| Parameter | Value / Description |
|---|---|
| Sample Type | Nasopharyngeal swab, BAL, sputum |
| Total Targets | 47 (17 Viral, 15 Bacterial, 5 Atypical, 7 AMR) |
| Detection Method | Qualitative Multiplex Real-Time RT-PCR |
| Internal Control | Included |
| Intended Use | In Vitro Diagnostic (IVD) |
| Storage | -20°C |
For in vitro diagnostic use. Contact your regional distributor or ProbGen representative to place an order.
| Product Name | Cat. No. | Pack Size |
|---|---|---|
| Genplex™ Respiratory & Pneumonia Panel | GP1064 | 48 tests |
| Genplex™ Respiratory & Pneumonia Panel | GP1065 | 96 tests |
Contact our scientific team for technical specifications, bulk pricing, or to request a demonstration of our diagnostics solutions.
Contact Us All Products